<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01258036</url>
  </required_header>
  <id_info>
    <org_study_id>C09-37</org_study_id>
    <secondary_id>2009-A01295-52</secondary_id>
    <nct_id>NCT01258036</nct_id>
  </id_info>
  <brief_title>Mother Daughter Bone Microarchitecture</brief_title>
  <acronym>MODAM</acronym>
  <official_title>Rôle de la Microarchitecture Osseuse Dans le déterminisme héréditaire de la fragilité Osseuse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to analyze the hereditary determinism of bone microarchitecture
      measured at the distal radius and distal tibia from a case control-study of mother-daughter
      pairs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many factors influence the risk of osteoporosis but one of the most important is a positive
      family history, emphasizing the importance of genetics in the pathogenesis of osteoporosis.
      Till now, most genetic studies in osteoporosis have focused on the phenotype of BMD. However,
      areal BMD (bone quantity per unit bone area measured) does not provide information regarding
      bone distribution (between cortical and cancellous compartments) or bone microarchitecture
      (trabecular number, thickness, spacing and distribution) and cortical (thickness, porosity).
      We are planning to analyze the hereditary determinism of bone microarchitecture assessed non
      invasively with HR pQCT at the distal radius and the distal tibia in a case-control study
      with fractured and not fractured mothers and their daughters. Additionally, the role of the
      bone turnover, hormones involved in regulating bone metabolism , bone geometry measured at
      the proximal femur and bone strength estimated by finite element analysis (μFE)in the
      hereditary determinism of bone fragility will be analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Role of bone microarchitecture in the hereditary determinism of bone fragility</measure>
    <time_frame>18 months</time_frame>
    <description>Comparison of bone microarchitecture parameters from high resolution peripheral quantitative computer tomography (HRpQCT)between daughters according to the fracture status of their mother.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Role of Bone mineral density in the hereditary determinism of bone fragility</measure>
    <time_frame>18 months</time_frame>
    <description>Comparison of BMD from DXA at the hip, the lumbar spine, the forearm and whole body, between daughters according to the fracture status of their mother.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Role of bone turnover and hormones in the hereditary determinism of bone fragility</measure>
    <time_frame>24 months</time_frame>
    <description>Comparison of Bone markers and hormone levels between daughters according to the fracture status of their mother.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1040</enrollment>
  <condition>Bone Fragility</condition>
  <arm_group>
    <arm_group_label>Fractured Mothers</arm_group_label>
    <description>Fractured Mothers and their daughters</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non fractured mothers</arm_group_label>
    <description>Mothers non fractured and their daughters</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>HRpQCT</intervention_name>
    <description>High Resolution peripheral Quantitative Computerized tomography</description>
    <arm_group_label>Fractured Mothers</arm_group_label>
    <arm_group_label>Non fractured mothers</arm_group_label>
    <other_name>XTreme CT,Scanco Medical, Bassersdorf, Switzerland</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Sampling</intervention_name>
    <description>Urine and blood samples</description>
    <arm_group_label>Fractured Mothers</arm_group_label>
    <arm_group_label>Non fractured mothers</arm_group_label>
    <other_name>Bone markers, hormones</other_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Bone absorptiometry</intervention_name>
    <description>DXA at the lumbar spine, hip, radius and whole body</description>
    <arm_group_label>Fractured Mothers</arm_group_label>
    <arm_group_label>Non fractured mothers</arm_group_label>
    <other_name>Hologic, Waltham,MA, USA</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum plasma urine whole blood for DNA extraction
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1. Fractured mothers and their daughters (case group)

          2. Non-fractured mothers and their daughters (control group)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Case mothers: postmenopausal women who have at least one bone fragility fracture
             confirmed by radiological examination or by a surgical report. Fragility fracture is a
             fracture that occurs as a result of a fall from standing height or less. Fractures of
             the skull, fingers and toes will be excluded.

          -  Control mothers: menopausal women not having suffered from bone fragility fracture.

          -  Daughters: Women aged 20 and older (postmenopausal or not), biological daughters of
             participating mothers. Several daughters from the same mother may be included.

        Mothers and some daughters are recruited from the OFELY (Os des FEmmes de LYon) cohort or
        the FMC (Filière MédicoChirurgicale).

        Exclusion Criteria:

          -  Adoptive daughters

          -  Nonmenopausal mothers
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisabeth Sornay-Rendu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roland D Chapurlat, MD PHD</last_name>
    <role>Study Director</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisabeth Sornay-Rendu, MD</last_name>
    <phone>33 4 72 11 74 44</phone>
    <email>elisabeth.rendu@inserm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Unité Inserm 831, Pavillon F, Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabteh Sornay-Rendu, MD</last_name>
      <phone>+331 4 72 11 74 44</phone>
      <email>elisabeth.rendu@inserm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2010</study_first_submitted>
  <study_first_submitted_qc>December 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2010</study_first_posted>
  <last_update_submitted>September 27, 2012</last_update_submitted>
  <last_update_submitted_qc>September 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bone microarchitecture</keyword>
  <keyword>Bone mineral density</keyword>
  <keyword>Bone markers</keyword>
  <keyword>hereditary determinism</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

